Fosmanogepix Uses, Dosage, Side Effects and more
Fosmanogepix is under investigation in clinical trial NCT03604705 (An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia).
| Trade Name | Fosmanogepix |
| Generic | Fosmanogepix |
| Fosmanogepix Other Names | Fosmanogepix |
| Type | |
| Formula | C22H21N4O6P |
| Weight | Average: 468.406 Monoisotopic: 468.11987141 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
